Latest Articles
Expert explains how weight cycling raises endometrial cancer risk | Tap to know more | Inshorts - Inshorts
Expert explains how weight cycling raises endometrial cancer risk | Tap to know more | Inshorts Inshorts
Published: Nov. 26, 2025, 11:03 a.m.
A STEM educator battles rare endometrial cancer - UT Physicians
A STEM educator battles rare endometrial cancer UT Physicians
Published: Nov. 25, 2025, 9:25 p.m.
NICE Recommends Jemperli With Chemotherapy for Advanced Endometrial Cancer - NAVLIN DAILY
NICE Recommends Jemperli With Chemotherapy for Advanced Endometrial Cancer NAVLIN DAILY
Published: Nov. 25, 2025, 2:06 p.m.
HAS Renews Early Access for Jemperli in Advanced Endometrial Cancer - NAVLIN DAILY
HAS Renews Early Access for Jemperli in Advanced Endometrial Cancer NAVLIN DAILY
Published: Nov. 24, 2025, 12:18 p.m.
Vivek Podder: Future Directions for ICI Rechallenge in Advanced Endometrial Cancer - Oncodaily
Vivek Podder: Future Directions for ICI Rechallenge in Advanced Endometrial Cancer Oncodaily
Published: Nov. 21, 2025, 4:19 p.m.
GSK preps lawsuit against US firm AnaptysBioover endometrial cancer drug - This is Money
GSK preps lawsuit against US firm AnaptysBioover endometrial cancer drug This is Money
Published: Nov. 21, 2025, 11:48 a.m.
Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression - springermedicine.com
Metabolomics reveals the therapeutic efficacy of liposomal resvida in endometrial cancer through regulating autophagy-related gene expression springermedicine.com
Published: Nov. 21, 2025, 2:26 a.m.
What Is the Role of ctDNA in Ovarian and Endometrial Cancers? - ASCO Daily News
What Is the Role of ctDNA in Ovarian and Endometrial Cancers? ASCO Daily News
Published: Nov. 21, 2025, 2:24 a.m.
Acute Cerebellitis Due to Administration of Durvalumab for Recurrent Endometrial Cancer: A Case Report - Cureus
Acute Cerebellitis Due to Administration of Durvalumab for Recurrent Endometrial Cancer: A Case Report Cureus
Published: Nov. 21, 2025, 1:57 a.m.
Molecular profiling of endometrial cancer in Martinique reveals frequent CCNE1 amplification in poor prognosis tumors - Nature
Molecular profiling of endometrial cancer in Martinique reveals frequent CCNE1 amplification in poor prognosis tumors Nature
Published: Nov. 19, 2025, 2:27 p.m.
Link copied to clipboard!